Needham downgraded Definitive Healthcare from Buy to Hold
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/9/2025 | Buy → Neutral | BTIG Research | |
| 1/13/2025 | $4.00 | Equal Weight → Underweight | Barclays |
| 12/20/2024 | $5.00 | Equal-Weight | Stephens |
| 9/17/2024 | $7.00 | Buy | BTIG Research |
| 7/31/2024 | $7.00 → $5.00 | Neutral → Underweight | JP Morgan |
| 5/8/2024 | $11.50 → $9.00 | Overweight → Equal-Weight | Morgan Stanley |
| 1/17/2024 | Buy → Hold | Needham | |
| 1/5/2024 | Buy → Hold | Canaccord Genuity |
BTIG Research downgraded Definitive Healthcare from Buy to Neutral
Barclays downgraded Definitive Healthcare from Equal Weight to Underweight and set a new price target of $4.00
Stephens initiated coverage of Definitive Healthcare with a rating of Equal-Weight and set a new price target of $5.00
FRAMINGHAM, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), a provider of healthcare data and analytics, today announced several product enhancements designed to give organizations a clearer view of the healthcare ecosystem and help them act on critical market intelligence faster. These updates include expanded medical claims coverage, a new integration for HubSpot, direct access to HCP data within Salesforce, and new AI search capabilities in key products. Together, they strengthen the company's core data foundation and make insights easier to access in the systems teams use every day, helping customers move faster, focus on the right opportunities, and make mo
FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended March 31, 2026. First Quarter 2026 Financial Highlights: Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. Net Loss, inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue. Adjusted Net Income was $8.5 million, compared to $7.0 million i
FRAMINGHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortl
4 - Definitive Healthcare Corp. (0001861795) (Issuer)
4 - Definitive Healthcare Corp. (0001861795) (Issuer)
4 - Definitive Healthcare Corp. (0001861795) (Issuer)
SCHEDULE 13G/A - Definitive Healthcare Corp. (0001861795) (Subject)
10-Q - Definitive Healthcare Corp. (0001861795) (Filer)
8-K - Definitive Healthcare Corp. (0001861795) (Filer)
FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended March 31, 2026. First Quarter 2026 Financial Highlights: Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. Net Loss, inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue. Adjusted Net Income was $8.5 million, compared to $7.0 million i
FRAMINGHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortl
FRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights: Revenue was $61.5 million, a decrease of 1% from $62.3 million in Q4 2024.Net Loss, inclusive of goodwill impairment charges of $19.5 million, was $(17.1) million, or (28)% of revenue, compared to $(84.7) million in Q4 2024, inclusive of goodwill impairment charges of $97.1 million, or (136)% of revenue.Adjusted Net Income was $8.6 million, compared to $12.6 millio
SC 13G - Definitive Healthcare Corp. (0001861795) (Subject)
SC 13G - Definitive Healthcare Corp. (0001861795) (Subject)
SC 13G/A - Definitive Healthcare Corp. (0001861795) (Subject)
FRAMINGHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that its Board of Directors has appointed Kevin Coop as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective June 24, 2024. Mr. Coop succeeds Jason Krantz, founder and Executive Chairman, who has been serving as Interim CEO since January 2024. Mr. Krantz will continue to serve on the Board of Directors as Executive Chairman after the CEO transition. "Kevin is an outstanding leader. He has deep, hands-on experience with data-focused businesses and has a
Jim Emling, the CEO of Datassential and former long-time president of Milwaukee-based Zywave, has been appointed Executive Chair of the Board of Directors at VBA, the company announced today. "We are delighted to welcome Jim officially to VBA as the Executive Chair," said Michael Clayton, the company's President and CEO. "Jim and I have worked closely together over the last 3 months and his decades of experience scaling high growth software companies combined with his strong ties to the Milwaukee technology sector will be tremendous assets to VBA as we enter our next phase of growth." Emling has deep roots in the Milwaukee technology community. He was the founding CTO of Zywave and serv
FRAMINGHAM, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that Carrie Lazorchak has been named Chief Revenue Officer, effective November 1, 2023. "I am thrilled to welcome Carrie Lazorchak to Definitive Healthcare as our new Chief Revenue Officer," said Robert Musslewhite, Chief Executive Officer of Definitive Healthcare. "Carrie is a fantastic fit for Definitive Healthcare. Her values and her deep belief in the power of humble collaboration make her a perfect match for our culture. Carrie brings a wealth of experience selling Software as a Service to both enterprise accounts and